Flu Virus
Showing 1 - 25 of 7,133
Bacterial Growth, Novel Influenza A (H1N1) Trial in Jilin (A novel electrolyzed water spray reduces numbers of bacteria E-coli
Recruiting
- Bacterial Growth
- Novel Influenza A (H1N1)
- A novel electrolyzed water spray reduces numbers of bacteria E-coli and an attenuated human flu virus on human hands
-
Jilin, Changchun, ChinaChangchun Jiahe Surgery Hospital
Apr 1, 2023
Respiratory Syncytial Virus Infections Trial in Saint Petersburg (RSV/Flu-01E low dose, RSV/Flu-01E high dose, Placebo)
Active, not recruiting
- Respiratory Syncytial Virus Infections
- RSV/Flu-01E low dose
- +2 more
-
Saint Petersburg, Russian FederationSmorodintsev Research Institute of Influenza
Jul 24, 2023
COVID-19 Respiratory Infection, Influenza A, Influenza Type B Trial in Pasadena (Labcorp COVID-19+Flu+RSV Test Home Collection
Recruiting
- COVID-19 Respiratory Infection
- +3 more
- Labcorp COVID-19+Flu+RSV Test Home Collection Kit
-
Pasadena, CaliforniaExer Urgent Care
Aug 21, 2023
Influenza A, Influenza Type B, SARS CoV 2 Infection Trial in Raleigh (Diagnostic Test for identification of influenzas A,
Not yet recruiting
- Influenza A
- +3 more
- Diagnostic Test for identification of influenzas A, influenzas B, RSV and SARS-CoV-2 infections
-
Raleigh, North CarolinaWake Med
Jun 26, 2023
Influenza, Human Trial (FLU Q-PAN H5N8 Formulation 1, AS03B, AS03A)
Not yet recruiting
- Influenza, Human
- FLU Q-PAN H5N8 Formulation 1
- +3 more
- (no location specified)
Jul 27, 2023
Influenza, Human Trial in Sacramento (Procalcitonin, Pharmacist-Led Education)
Completed
- Influenza, Human
- Procalcitonin
- Pharmacist-Led Education
-
Sacramento, CaliforniaUniversity of California, Davis Medical Center
Aug 16, 2022
Project STARFISH - PRJ0002679
Not yet recruiting
- SARS-CoV-2 Infection
- +3 more
- The Applied Biosystems™ TaqPath™ COVID-19, Flu A, Flu B, RSV Select Panel
- (no location specified)
Feb 14, 2023
Influenza, Influenza, Human, Influenza Viral Infections Trial in Russian Federation (Influenza vaccine [inactivated])
Completed
- Influenza
- +4 more
- Influenza vaccine [inactivated]
-
Kol'tsovo, Novosibirsk Region, Russian Federation
- +4 more
May 11, 2023
Influenza, Influenza, Human, Influenza Viral Infections Trial in Russian Federation (Influenza vaccine [inactivated])
Recruiting
- Influenza
- +3 more
- Influenza vaccine [inactivated]
-
Ekaterinburg, Russian Federation
- +6 more
Feb 13, 2023
Healthy Trial in Buenos Aires (RSVpreF+qIRV, qIRV, RSVpreF)
Recruiting
- Healthy
- RSVpreF+qIRV
- +3 more
-
Buenos Aires, ArgentinaHospital Militar Central Cirujano Mayor Dr. Cosme Argerich
Mar 27, 2023
Respiratory Syncytial Virus Infections Trial in New Zealand, Panama, South Africa (RSVPreF3 OA investigational vaccine, FLU-QIV)
Completed
- Respiratory Syncytial Virus Infections
- RSVPreF3 OA investigational vaccine
- FLU-QIV
-
Auckland, New Zealand
- +13 more
Sep 20, 2022
ARDS, Human, Covid19 Trial in Miami, Baltimore, Winston-Salem (Longeveron Mesenchymal Stem Cells (LMSCs), Placebo)
Recruiting
- ARDS, Human
- Covid19
- Longeveron Mesenchymal Stem Cells (LMSCs)
- Placebo
-
Miami, Florida
- +2 more
Nov 3, 2022
Understanding Immunity to the Flu Vaccine in COVID-19 Patients
Completed
- Corona Virus Infection
- +2 more
- Flu shot
-
Stanford, CaliforniaStanford University, Hospital, and Clinics
Sep 14, 2021
Plasma Cell Tumor Trial in Atlanta (Pneumococcal 13-valent Conjugate Vaccine, Trivalent Influenza Vaccine)
Active, not recruiting
- Plasma Cell Neoplasm
- Pneumococcal 13-valent Conjugate Vaccine
- Trivalent Influenza Vaccine
-
Atlanta, Georgia
- +1 more
Jan 24, 2022
Herpes Zoster Trial in Tomball (HZ/su, Flu D-QIV, mRNA-1273)
Active, not recruiting
- Herpes Zoster
- HZ/su
- +2 more
-
Tomball, TexasGSK Investigational Site
Apr 8, 2022
Respiratory Syncytial Virus Infections Trial (RSVPreF3 OA investigational vaccine, FLU vaccine)
Active, not recruiting
- Respiratory Syncytial Virus Infections
- RSVPreF3 OA investigational vaccine
- FLU vaccine
-
Edegem, Belgium
- +33 more
Dec 7, 2022
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Columbus (biological, drug, other)
Active, not recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine Adsorbed
- +6 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Feb 24, 2022
Qualitative, Qualitative, and Functional Studies Over First Year
Completed
- Astrocytoma
- +2 more
- Hepatitis A Vaccine
- +3 more
-
Winston-Salem, North CarolinaComprehensive Cancer Center of Wake Forest University
Oct 28, 2021
Respiratory Syncytial Virus Infections Trial in United States (RSVPreF3 OA investigational vaccine, FLU HD vaccine)
Active, not recruiting
- Respiratory Syncytial Virus Infections
- RSVPreF3 OA investigational vaccine
- FLU HD vaccine
-
Birmingham, Alabama
- +46 more
Jan 12, 2023
Influenza, Human Trial in United States (FLU-Q-PAN H7N9 Formulation 1, FLU-Q-PAN H7N9 Formulation 2, FLU-Q-PAN H7N9 Formulation
Active, not recruiting
- Influenza, Human
- FLU-Q-PAN H7N9 Formulation 1
- +5 more
-
Stockbridge, Georgia
- +6 more
Apr 18, 2022
Influenza, Influenza Immunisation Trial in Rochester (Influenza Virus Quadrivalent Inactivated Vaccine)
Completed
- Influenza
- Influenza Immunisation
- Influenza Virus Quadrivalent Inactivated Vaccine
-
Rochester, New York
- +1 more
Apr 29, 2021
Respiratory Syncytial Virus Infections Trial in Worldwide (RSV MAT Lot 1 vaccine (GSK3888550A), RSV MAT Lot 2 vaccine
Completed
- Respiratory Syncytial Virus Infections
- RSV MAT Lot 1 vaccine (GSK3888550A)
- +4 more
-
West Palm Beach, Florida
- +35 more
Jul 14, 2022
Respiratory Virus Hospitalization Study (FLU 003 Plus)
Recruiting
- Influenza
- +2 more
-
San Diego, California
- +62 more
Mar 28, 2022
Influenza Trial in Atlanta (Influenza Vaccine)
Not yet recruiting
- Influenza
- Influenza Vaccine
-
Atlanta, GeorgiaEmory University Hospital
Dec 7, 2022